These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8192153)

  • 1. Familial myeloproliferative syndrome.
    Pérez-Encinas M; Bello JL; Pérez-Crespo S; De Miguel R; Tome S
    Am J Hematol; 1994 Jul; 46(3):225-9. PubMed ID: 8192153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
    Tefferi A
    Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic myeloproliferative diseases].
    Sréter L
    Orv Hetil; 1998 Jul; 139(30):1779-83. PubMed ID: 9718944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary hypertension in patients with myelofibrosis secondary to myeloproliferative diseases.
    García-Manero G; Schuster SJ; Patrick H; Martinez J
    Am J Hematol; 1999 Feb; 60(2):130-5. PubMed ID: 9929105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncontrolled thrombocytosis in chronic myeloproliferative disorders.
    Kessler CM; Klein HG; Havlik RJ
    Br J Haematol; 1982 Jan; 50(1):157-67. PubMed ID: 6976793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
    Iványi JL; Marton E; Plander M
    Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of the frequency of JAK2 (V617F) mutation in different myeloproliferative disorders in Egyptian patients.
    Ebid GT; Ghareeb M; Salaheldin O; Kamel MM
    Int J Clin Exp Pathol; 2015; 8(9):11555-9. PubMed ID: 26617890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon in the treatment of myeloproliferative diseases.
    Silver RT
    Semin Hematol; 1990 Jul; 27(3 Suppl 4):6-14. PubMed ID: 2115694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
    Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloproliferative neoplasms cause glomerulopathy.
    Said SM; Leung N; Sethi S; Cornell LD; Fidler ME; Grande JP; Herrmann S; Tefferi A; D'Agati VD; Nasr SH
    Kidney Int; 2011 Oct; 80(7):753-9. PubMed ID: 21654720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of beta-catenin in chronic myeloproliferative disorders.
    Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
    Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of the activating mutation Val617Phe of Janus kinase 2 gene in myeloproliferative diseases and significance of its detection].
    Andrikovics H; Szilvási A; Meggyesi N; Király V; Halm G; Lueff S; Nahajevszky S; Mikala G; Sipos A; Lovas N; Csukly Z; Mátrai Z; Tamáska J; Tordai A; Masszi T
    Orv Hetil; 2007 Feb; 148(5):203-10. PubMed ID: 17344140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Familial myeloproliferative syndromes. Study of 6 families and review of literature].
    Kaufman S; Brière J; Bernard J
    Nouv Rev Fr Hematol (1978); 1978 Apr; 20(1):1-15. PubMed ID: 353725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia.
    Mesa RA; Elliott MA; Tefferi A
    Blood Rev; 2000 Sep; 14(3):121-9. PubMed ID: 10986148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic myeloproliferative syndromes].
    de Ozalla CB; García Suárez J
    Rev Clin Esp; 1999 Apr; 199 Suppl 1():28-36. PubMed ID: 10422448
    [No Abstract]   [Full Text] [Related]  

  • 16. Hematopathologic findings in the myeloproliferative disorders.
    Dickstein JI; Vardiman JW
    Semin Oncol; 1995 Aug; 22(4):355-73. PubMed ID: 7638633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic myeloid leukemia with progression to polycythemia vera].
    Campo MC; Fortún A; Travieso J
    Sangre (Barc); 1992 Jun; 37(3):207-8. PubMed ID: 1440100
    [No Abstract]   [Full Text] [Related]  

  • 18. BCR-ABL1- positive chronic myeloid leukemia with erythrocytosis presenting as polycythemia vera: a case report.
    Cornea MI; Levrat E; Pugin P; Betticher DC
    J Med Case Rep; 2015 Apr; 9():30. PubMed ID: 26187587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
    Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of interferon in the treatment of chronic myeloproliferative disorders].
    Robak T
    Acta Haematol Pol; 1992; 23(2 Suppl 1):30-7. PubMed ID: 1488870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.